Stockscreener 앱 받기
0.9368
2.23%
0.0204
시장 영업 전:
.93
-0.0068
-0.73%
Femasys Inc 주식(FEMY)의 최신 뉴스
What analysts say about Femasys Inc. stockConsistent triple-digit returns - Jammu Links News
How Femasys Inc. stock performs during market volatilityPrecision Entry Strategy - Newser
What makes Femasys Inc. stock price move sharplyVolume Spike Monitors - Newser
Why Femasys Inc. stock attracts strong analyst attentionQuick Profit Idea Stream - Newser
Femasys Secures $10 Million Financing with Alumni Capital Purchase Agreement - AInvest
XENE CEO Named Interim CFO After Sherry Aulin Resigns | FEMY SEC FilingForm 8-K - Stock Titan
Major Breakthrough: Australia and NZ Approve Femasys Revolutionary First-Line Infertility Solutions - Stock Titan
Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed® for First-Line Infertility Treatment and FemVue Diagnostic - The Manila Times
Femasys Gains Regulatory Approvals in Australia and New Zealand - TipRanks
Femasys Enters Purchase Agreement with Alumni Capital - TipRanks
Femasys stock rises as FemBloc gets CE Mark for permanent birth control - Investing.com Canada
Femasys Receives European Approval for FemBloc Non-Surgical Permanent Birth Control - Femtech Insider
Femasys appoints Kelley Nicholas as chief commercial officer - Investing.com
Femasys appoints Kelley Nicholas as chief commercial officer By Investing.com - Investing.com Canada
Femasys Appoints Kelley Nicholas as Chief Commercial Officer - TipRanks
Femasys (FEMY) Appoints Kelley Nicholas as Chief Commercial Officer | FEMY Stock News - GuruFocus
Femasys appoints Nicholas as CCO - TipRanks
Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth - GlobeNewswire
Femasys Inc. (FEMY) Reports Q1 Loss, Misses Revenue Estimates - MSN
40,968 Shares in Femasys Inc. (NASDAQ:FEMY) Acquired by Citadel Advisors LLC - Defense World
Femasys (NASDAQ:FEMY) Receives “Buy” Rating from HC Wainwright - Defense World
A Closer Look at Femasys Inc (FEMY) Stock Gains - investchronicle.com
The Analyst Verdict: Femasys In The Eyes Of 6 Experts - Benzinga
Femasys (FEMY): Buy Rating Reiterated by HC Wainwright & Co. | FEMY Stock News - GuruFocus
Femasys: Strategic Partnerships and Revenue Growth Drive Buy Rating with $12 Price Target - TipRanks
Femasys Announces Partnership with Carolinas Fertility - GlobeNewswire
Femasys announces partnership with Carolinas Fertility Institute - TipRanks
Femasys (FEMY) Partners with Carolinas Fertility Institute for FemaSeed Distribution | FEMY Stock News - GuruFocus
Major Fertility Breakthrough: Leading US Clinic Network Adopts Femasys FemaSeed as IVF Alternative - Stock Titan
Jane Street Group LLC Acquires New Stake in Femasys Inc. (NASDAQ:FEMY) - Defense World
Femasys Executives Make Bold Moves with Major Stock Purchases! - TipRanks
Northern Trust Corp Purchases 37,675 Shares of Femasys Inc. (NASDAQ:FEMY) - Defense World
Femasys Stock Slides After Company Prices Public Offering At Discount: Retail’s Planning To Load Up - Asianet Newsable
Femasys Announces Public Offering and Private Placement - TipRanks
Femasys announces pricing of underwritten public offering and concurrent private placement with gross proceeds of $4.5M - MSN
Femasys sets pricing for stock offering and private placement By Investing.com - Investing.com South Africa
Femasys stock hits 52-week low at $0.82 amid market challenges By Investing.com - Investing.com South Africa
FEMY Announces Public Offering and Private Placement Pricing | F - GuruFocus
Femasys stock hits 52-week low at $0.82 amid market challenges - Investing.com Canada
Femasys Announces $4.5 Mln Offering Through Public Sale And Private Placement Of Shares - Nasdaq
Femasys prices 3.6M shares at 85c in underwritten public offering - TipRanks
Femasys (FEMY) Announces Stock Offering to Raise $4.5 Million - GuruFocus
Femasys Stock Slides After Company Prices Public Offering At Discount: Retail’s Planning To Load Up By Stocktwits - Investing.com India
FEMY Announces Public Offering and Private Placement Pricing | FEMY Stock News - GuruFocus
Femasys sets pricing for stock offering and private placement - Investing.com
Femasys Announces Pricing Of Underwritten Public Offering And Concurrent Private Placement With Gross Proceeds Of $4.5 Million - marketscreener.com
Femasys Announces Pricing of Underwritten Public Offering - GlobeNewswire
Women's Health Innovator Femasys Secures $4.5M Strategic Financing to Accelerate Commercial Growth - Stock Titan
1.14%
1.69%
자본화:
|
볼륨(24시간):